查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1572018

經皮腎結石清除的全球市場

Percutaneous Nephrolithotomy
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 93 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球經皮腎結石清除市場預計將達到 4.452 億美元

經皮鏡取石術的全球市場預計 2023 年為 3.284 億美元，預計到 2030 年將達到 4.452 億美元，預測在 2023-2030 年分析期間複合年成長率為 4.4%。

美國市場預估為8,770萬美元，中國預期複合年成長率為6.6%

預計 2023 年美國經皮取石術市場規模將達 8,770 萬美元。中國作為世界第二大經濟體，預計到 2030 年市場規模將達到 9,360 萬美元，2023-2030 年分析期間複合年成長率為 6.6%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 2.5% 和 4.2%。在歐洲，德國的複合年成長率預計為 2.7%。

全球經皮皮腎結石清除市場 – 主要趨勢與促進因素

什麼是經皮皮腎結石清除術？

經皮鏡取石術（PCNL）用於清除無法透過體外震波碎石術（ESWL）或輸尿管鏡檢查等微創技術有效治療的大型或複雜腎結石。但PCNL有什麼特點以及為什麼選擇它來治療大腎結石呢？此手術需要在患者背部切割一個小切口（通常小於 1 公分），然後將腎鏡（一種特殊的手術器械）直接插入腎臟。這使得外科醫生能夠看到結石並使用器械將其打碎並取出。通常會暫時放置一根管子，以確保手術後適當引流和癒合。 PCNL 對於直徑大於 2 公分的結石、棘狀結石和位於腎臟內困難解剖位置的結石特別有效。此手術效率很高，大多數情況下結石清除率超過 90%，使其成為一次治療大結石或多顆結石的好選擇。與開放性手術相比，PCNL具有術後疼痛輕度、住院時間短、恢復快等優點，為複雜腎結石需要明確解決方案的患者帶來巨大益處。

最近的技術進展如何提高 PCNL 的安全性和有效性？

經皮腎結石清除領域極大地受益於技術進步，顯著提高了手術的安全性、準確性和結果。最顯著的進步之一是手術器械的小型化，允許使用更小的腎鏡和稱為迷你 PCNL 和超迷你 PCNL 的接入管進行手術。此手術適用於兒童和成人患者，因為它可以降低出血風險並最大限度地減少對腎臟的創傷。另一個關鍵創新是使用先進的顯像模式，例如透視、超音波和即時 CT 引導，以實現更精確的結石定位和更安全的腎臟，即使在解剖結構複雜的情況下也是如此。此外，更新的碎石設備，包括雷射和氣動設備，增加了碎石的能力，減少了翻修手術的需要。這些能源來源提高了效率，使外科醫生能夠更快地打碎較大的結石，同時保護健康組織。 PCNL 機器人技術和電腦輔助導航的整合也即將到來，預計將進一步提高泌尿系統的準確性並縮短學習曲線。此外，單步擴張技術和球囊擴張器簡化了腎造口術的製作過程，減少了手術時間和併發症率。這些進步使得PCNL不僅更安全，而且適用於更廣泛的患者群體，包括具有複雜腎臟解剖結構、單一腎臟和多種併發症的患者，使其更符合現代泌尿系統，效用正在擴大。

為什麼 PCNL 成為各種患者群體的首選治療方法？

經皮取石術在不同患者群體中的採用率穩步增加，反映了其在複雜結石疾病中的多功能性和有效性。在成年人中，PCNL 正在成為治療大結石、多發性結石以及非侵入性方法失敗時的首選。 PCNL 具有較高的結石清除成功率和相對較低的復發率，使其成為尋求結石疾病明確解決方案的患者的一個有吸引力的選擇。由於小型儀器和低風險手術的發展，小兒泌尿系統是 PCNL 變得越來越流行的另一個領域。對於兒童來說，PCNL 為治療有症狀的結石提供了安全的選擇，否則需要多次手術。經常患有多種併發症的老年患者也受益於 PCNL 的微創特性，與開放性手術相比，其併發症率較低。此外，由於手術的高度適應性以及外科醫生使用專用設備的能力，患有獨特解剖學挑戰的患者（例如患有馬蹄腎或孤立性腎病的患者）擴大接受 PCNL。 PCNL 的範圍正在進一步擴大，包括肥胖患者，經皮方法比更具侵入性的選擇具有明顯的優勢，可以減少手術負擔和恢復時間。 PCNL 在如此多樣化的患者群體中得到廣泛接受，不僅證明了該手術的多功能性，而且還證明了泌尿系統客製化 PCNL 手術以滿足不同患者群體的特定需求的能力。

是什麼推動了經皮腎結石清除市場的成長？

經皮腎結石市場的成長受到多種因素的推動，例如技術進步、腎結石盛行率上升以及患者和臨床醫生對微創選擇的認知不斷提高。主要成長要素之一是全球腎結石盛行率上升，這與飲食習慣、肥胖、代謝異常等生活方式因素密切相關。隨著腎結石在各個年齡層變得越來越常見，對 PCNL 等有效手術治療的需求不斷成長。此外，手術設備和診斷影像設備的技術創新提高了 PCNL 的安全性和準確性，使其成為更廣泛的患者的可行選擇，包括那些具有複雜解剖結構和高風險特徵的患者。隨著更小型儀器的出現，PCNL 的患者群體正在擴大，特別是在兒科和老年醫學領域，傳統的 PCNL 被認為侵入性太強。另一個重要因素是患者和醫療保健提供者越來越偏好微創手術，從而縮短復原時間、減少併發症並改善美容效果。泌尿系統專科中心的增加以及接受過先進 PCNL 技術培訓的熟練外科醫生的出現也有助於市場擴張。此外，監管機構對新 PCNL 設備的核准以及旨在改善專業外科護理機會的支持性醫療政策正在鼓勵更廣泛的採用。機器人系統和電腦輔助導航的整合有望進一步推動市場，因為它是一項有望提高準確性並縮短程式學習曲線的技術。這些因素共同塑造了 PCNL 市場的發展軌跡，並隨著對有效微創腎結石治療的需求持續上升，使其實現強勁成長。

受訪企業範例（共42例）

  • Boston Scientific Corporation
  • Cook Medical
  • Electro Medical Systems SA
  • innoMedicus AG
  • Karl Storz Se & Co. KG
  • Olympus Corporation
  • PolyDiagnost

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP17592

Global Percutaneous Nephrolithotomy Market to Reach US$445.2 Million by 2030

The global market for Percutaneous Nephrolithotomy estimated at US$328.4 Million in the year 2023, is expected to reach US$445.2 Million by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030.

The U.S. Market is Estimated at US$87.7 Million While China is Forecast to Grow at 6.6% CAGR

The Percutaneous Nephrolithotomy market in the U.S. is estimated at US$87.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$93.6 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Percutaneous Nephrolithotomy Market - Key Trends and Drivers Summarized

What Is Percutaneous Nephrolithotomy and Why Is It the Preferred Treatment for Large Kidney Stones?

Percutaneous Nephrolithotomy (PCNL) is a minimally invasive surgical procedure used to remove large or complex kidney stones that cannot be effectively treated through less invasive techniques such as extracorporeal shock wave lithotripsy (ESWL) or ureteroscopy. But what makes PCNL distinct and why is it the go-to choice for large renal calculi? The procedure involves making a small incision, usually less than one centimeter, in the patient’s back through which a nephroscope—a specialized surgical instrument—is inserted directly into the kidney. This allows the surgeon to visualize the stones and use instruments to break them into smaller pieces for removal. A tube is often placed temporarily to ensure proper drainage and healing post-procedure. PCNL is particularly effective for stones larger than 2 cm in diameter, staghorn stones, or when stones are located in challenging anatomical locations within the kidney. The technique is highly efficient, with a stone clearance rate exceeding 90% in most cases, making it the preferred option for treating large or multiple stones in a single setting. Compared to open surgery, PCNL is associated with less postoperative pain, shorter hospital stays, and quicker recovery times, providing a significant advantage to patients who need a definitive solution to complex kidney stones.

How Have Recent Technological Advances Enhanced the Safety and Efficacy of PCNL?

The field of Percutaneous Nephrolithotomy has benefited immensely from technological advancements that have significantly improved the safety profile, precision, and outcomes of the procedure. One of the most noteworthy developments is the miniaturization of surgical instruments, leading to what is known as mini-PCNL or ultra-mini-PCNL, which uses even smaller nephroscopes and access tracts. This technique reduces the risk of bleeding and minimizes trauma to the kidney, making it suitable for pediatric patients and adults alike. Another pivotal innovation is the use of advanced imaging modalities, such as fluoroscopy, ultrasound, and real-time CT guidance, which allow for more precise stone targeting and safer access to the kidney, even in anatomically complex cases. Furthermore, new lithotripters, including laser and pneumatic devices, provide enhanced power for fragmenting hard stones, thus reducing the need for repeat procedures. These energy sources have improved efficiency, allowing surgeons to break down larger stones more quickly while preserving healthy tissue. The integration of robotics and computer-assisted navigation in PCNL is also on the horizon, promising to further increase accuracy and reduce the learning curve for urologists. Additionally, single-step dilation techniques and balloon dilators have simplified the process of creating the nephrostomy tract, decreasing operative time and lowering the incidence of complications. With these advancements, PCNL has become not only safer but also more adaptable to a wider range of patient profiles, including those with complex renal anatomy, solitary kidneys, or multiple co-morbidities, thereby expanding its utility in modern urological practice.

Why Is PCNL Becoming the Preferred Treatment Option Across Different Patient Demographics?

The adoption of Percutaneous Nephrolithotomy is steadily increasing across various patient demographics, reflecting its versatility and efficacy in addressing complex stone disease. In adult populations, PCNL is becoming the first-line option for managing large or multiple stones, as well as for cases where non-invasive methods have failed. The procedure’s high success rate in clearing stones, combined with its relatively low recurrence rate, makes it an attractive choice for patients seeking a definitive solution to their condition. Pediatric urology is another area where PCNL is gaining traction, thanks to the development of miniaturized instruments and lower-risk techniques. In children, PCNL offers a safe alternative for treating symptomatic stones that would otherwise require multiple procedures. Elderly patients, who often present with multiple comorbid conditions, also benefit from PCNL’s minimally invasive nature, which results in a lower overall complication rate compared to open surgery. Moreover, individuals with unique anatomical challenges, such as horseshoe kidneys or patients with a solitary kidney, are increasingly undergoing PCNL due to the procedure’s adaptability and the surgeon’s ability to tailor the approach using specialized equipment. The application of PCNL is further expanding to include obese patients, where the percutaneous approach offers a clear advantage over more invasive options, reducing surgical stress and recovery time. This broadening acceptance of PCNL across diverse patient groups is not just a testament to the procedure’s versatility but also to the growing expertise of urologists in customizing PCNL techniques to meet the specific needs of different patient populations.

What’s Fueling the Growth of the Percutaneous Nephrolithotomy Market?

The growth in the Percutaneous Nephrolithotomy market is driven by several factors, including technological advancements, the rising incidence of kidney stone disease, and increasing patient and clinician awareness of minimally invasive options. One of the primary growth drivers is the global rise in the prevalence of nephrolithiasis, which is closely linked to lifestyle factors such as dietary habits, obesity, and metabolic disorders. With kidney stone disease becoming more common across age groups, there is a growing demand for effective surgical treatments like PCNL. Additionally, technological innovations in surgical equipment and imaging modalities are enhancing the safety and precision of PCNL, making it a more viable option for a broader range of patients, including those with complex anatomy or high-risk profiles. The availability of miniaturized instruments has expanded the patient base for PCNL, particularly in pediatric and geriatric care, where traditional PCNL might have been deemed too invasive. Another key factor is the increasing preference among patients and healthcare providers for minimally invasive procedures, which are associated with shorter recovery times, fewer complications, and better cosmetic outcomes. The growth of specialized urology centers and the presence of skilled surgeons who are trained in advanced PCNL techniques are also contributing to market expansion. Moreover, regulatory approval of new PCNL devices and supportive healthcare policies aimed at improving access to specialized surgical care are encouraging more widespread adoption. The integration of robotic systems and computer-assisted navigation is poised to further propel the market, as these technologies promise to enhance precision and reduce the procedural learning curve. Collectively, these factors are shaping the trajectory of the PCNL market, positioning it for robust growth as the demand for effective and minimally invasive kidney stone treatments continues to rise.

Select Competitors (Total 42 Featured) -

  • Boston Scientific Corporation
  • Cook Medical
  • Electro Medical Systems SA
  • innoMedicus AG
  • Karl Storz Se & Co. KG
  • Olympus Corporation
  • PolyDiagnost

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Percutaneous Nephrolithotomy - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Kidney Stones Globally Spurs Demand for Minimally Invasive Surgical Techniques
    • Advancements in Imaging Technologies Strengthen the Business Case for PCNL in Complex Stone Management
    • Rising Adoption of Miniaturized Instruments Expands Addressable Market Opportunity in Pediatric and Geriatric Segments
    • Integration of Robotics and Computer-Assisted Navigation Propels Market Growth in High-Precision Stone Removal
    • Improved Post-Operative Outcomes and Reduced Recovery Times Sustain Growth of PCNL in High-Risk Patient Groups
    • Surge in Health Awareness and Early Diagnosis Accelerates Demand for Surgical Stone Management Solutions
    • Technological Innovations in Lithotripters and Energy Sources Strengthen PCNL's Position in the Kidney Stone Treatment Spectrum
    • Rising Geriatric Population and Associated Urological Disorders Expand the Addressable Market for PCNL
    • Increasing Medical Tourism in Emerging Markets Generates New Opportunities for PCNL Procedures
    • High Incidence of Lifestyle-Related Risk Factors for Nephrolithiasis Creates Sustained Demand for Surgical Interventions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Percutaneous Nephrolithotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Percutaneous Nephrolithotomy Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 5: USA Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 6: USA Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • CANADA
    • TABLE 7: Canada Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 8: Canada Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • JAPAN
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 9: Japan Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 10: Japan Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • CHINA
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 11: China Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 12: China Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • EUROPE
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 13: Europe Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: Europe Historic Review for Percutaneous Nephrolithotomy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: Europe 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 16: France Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 17: France Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • GERMANY
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 18: Germany Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 19: Germany Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ITALY
    • TABLE 20: Italy Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Italy Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • UNITED KINGDOM
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 22: UK Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: UK Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • SPAIN
    • TABLE 24: Spain Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Spain Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • RUSSIA
    • TABLE 26: Russia Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Russia Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF EUROPE
    • TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Rest of Europe Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ASIA-PACIFIC
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 31: Asia-Pacific Historic Review for Percutaneous Nephrolithotomy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 32: Asia-Pacific 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • AUSTRALIA
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 33: Australia Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 34: Australia Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • INDIA
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 35: India Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: India Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • SOUTH KOREA
    • TABLE 37: South Korea Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 38: South Korea Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF ASIA-PACIFIC
    • TABLE 39: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 40: Rest of Asia-Pacific Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • LATIN AMERICA
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 41: Latin America Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 42: Latin America Historic Review for Percutaneous Nephrolithotomy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Latin America 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 44: Argentina Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Argentina Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • BRAZIL
    • TABLE 46: Brazil Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Brazil Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • MEXICO
    • TABLE 48: Mexico Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Mexico Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF LATIN AMERICA
    • TABLE 50: Rest of Latin America Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Latin America Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • MIDDLE EAST
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 52: Middle East Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 53: Middle East Historic Review for Percutaneous Nephrolithotomy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 54: Middle East 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • IRAN
    • TABLE 55: Iran Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 56: Iran Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ISRAEL
    • TABLE 57: Israel Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 58: Israel Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • SAUDI ARABIA
    • TABLE 59: Saudi Arabia Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Saudi Arabia Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • UNITED ARAB EMIRATES
    • TABLE 61: UAE Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 62: UAE Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF MIDDLE EAST
    • TABLE 63: Rest of Middle East Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 64: Rest of Middle East Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • AFRICA
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 65: Africa Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Africa Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

IV. COMPETITION